ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
58,639.82
0.69%
S&P 500
5,018.39
0.00%
Dow Jones
37,903.29
0.00%
US Dollar vs Yen
154.537
-0.76%
Brent Oil
83.755
0.26%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) ニュース

TBPH Theravance Biopharma Inc

8.84
0.00 (0.00%)
プレマーケット
最終更新日： 20:00:00
15分遅延
名称 銘柄コード 市場 種別
Theravance Biopharma Inc TBPH NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 8.84 20:00:00
始値 安値 高値 終値 前日終値
8.84
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2919:00PRNUSTheravance Biopharma to Report First Quarter 2024 Financial..
2024/4/1019:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
2024/2/2706:16EDGAR2Form 8-K - Current report
2024/2/2706:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
2024/2/2310:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2310:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2220:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
2024/2/1710:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/1506:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1420:00PRNUSTheravance Biopharma to Report Fourth Quarter and Full Year..
2024/1/1620:16EDGAR2Form 8-K - Current report
2024/1/0520:07EDGAR2Form 8-K - Current report
2024/1/0520:00PRNUSTheravance Biopharma Announces Results from the Phase 4..
2023/12/2820:01EDGAR2Form 8-K - Current report
2023/12/2708:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2708:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/12/2207:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/2207:06EDGAR2Form 8-K - Current report
2023/12/2207:00PRNUSTheravance Biopharma, Inc. Announces Appointment of Jeremy..
2023/12/1820:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
2023/11/2308:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2308:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1708:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1620:00PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
2023/11/1520:00PRNUSTheravance Biopharma to Participate in the 6th Annual..
2023/11/1322:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
2023/11/1006:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:53EDGAR2Form 8-K - Current report
2023/11/0806:28PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2023..
2023/11/0207:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3106:15EDGAR2Form 8-K - Current report
2023/10/1919:00PRNUSTheravance Biopharma to Report Third Quarter 2023 Financial..
2023/10/1907:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1705:13EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1907:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1505:24EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1219:05EDGAR2Form 8-K - Current report
2023/8/2919:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
2023/8/2819:05PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
2023/8/2507:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2307:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2307:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1607:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
TBPH
Theravance Biopharma
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有